For instance, the overexpression of BCL2, which is an important antiapoptotic protein in AML, led to the development of BCL2 inhibitors to promote the induction of apoptosis in AML cells and has led to the discovery of venetoclax, a potent and selective BCL2 inhibitor [115]. The gene discussed is BCL2; the disease is acute myeloid leukemia.